Pinnacle Biologics Release: Children's Hospital of Wisconsin and Medical College of Wisconsin Launch Clinical Trial for Treatment of Childhood Brain Tumors
4/2/2013 3:32:53 PM
More...
|
Pinnacle Biologics Acquires PDT Laser Technology
12/5/2012 9:15:44 AM
More...
|
Pinnacle Biologics and INTERmedic Medical Devices Announce Strategic Manufacturing and Distribution Agreement for Cancer Laser Technology
6/27/2012 11:33:14 AM
More...
|
Pinnacle Biologics Announces the Appointment of Healthcare Executives Robert S. Altman as Chief Commercial Officer and Sharon Ayd as Chief Scientific Officer
6/5/2012 10:40:32 AM
More...
|
Pinnacle Biologics Announces Appointment of Bioprojet as Exclusive Distributor in Select European Countries
4/19/2012 9:37:41 AM
More...
|
Pinnacle Biologics Announces the Successful Completion of a Financing Round
1/10/2012 9:46:46 AM
More...
|
Treatment of Patients With Malignant Mesothelioma Utilizing Photodynamic Therapy With Pinnacle Biologics' Compound PHOTOFRIN(R) - Obtains FDA Orphan Drug Designation
12/15/2011 10:02:48 AM
More...
|
Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN(R) in the Treatment of Patients With Malignant Mesothelioma.
10/25/2011 5:54:59 AM
More...
|
Pinnacle Biologics Appoints ALKOPHARMA SA Its Exclusive Distributor For PDT (Photodynamic Therapy), in Select European Countries, Middle East And South East Asian Territories
9/20/2011 2:57:33 PM
More...
|
Pinnacle Biologics Acquires PHOTOFRIN(R) and PHOTOBARR(R), Novel Photodynamic Therapy for Treating Various Types of Cancer
3/29/2011 8:34:23 AM
More...
|
|